Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3869011 | The Journal of Urology | 2009 | 7 Pages |
Abstract
Alterations in p53 represent a highly promising marker of disease recurrence and cancer specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Analysis confirmed previous findings and showed that considering p53 can result in substantial accuracy gains relative to the use of standard predictors. The value and the level of the current evidence clearly exceed previous proof of the independent predictor status of p53 for predicting recurrence and cancer specific mortality.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Shahrokh F. Shariat, Yair Lotan, Pierre I. Karakiewicz, Raheela Ashfaq, Hendrik Isbarn, Yves Fradet, Patrick J. Bastian, Matthew E. Nielsen, Umberto Capitanio, Claudio Jeldres, Francesco Montorsi, Stefan C. Müller, Jose A. Karam, Lukas C. Heukamp,